TY  - JOUR
AU  - Merlo, Anna
AU  - Bernardo-Castineira, Cristobal
AU  - Sáenz-de-Santa-María, Inés
AU  - Pitiot, Ana S.
AU  - Balbin, Milagros
AU  - Astudillo, Aurora
AU  - Valdes, Nuria
AU  - Scola, Bartolome
AU  - Del Toro, Raquel
AU  - Mendez-Ferrer, Simon
AU  - Piruat, Jose I.
AU  - Suarez, Carlos
AU  - Chiara, Maria-Dolores
PY  - 2017
DO  - 10.18632/oncotarget.14265
SN  - 1949-2553
UR  - http://hdl.handle.net/20.500.12105/5166
AB  - The hypoxia-inducible factor 1 alpha (HIF-1 alpha) and its microRNA target, miR-210, are candidate tumor-drivers of metabolic reprogramming in cancer. Neuroendocrine neoplasms such as paragangliomas (PGLs) are particularly appealing for understanding...
LA  - eng
PB  - Impact Journals
KW  - Succinate dehydrogenase
KW  - Hypoxia inducible factor
KW  - Von hippel lindau
KW  - Paragangliomas
KW  - miR-210
KW  - HIPPEL-LINDAU-DISEASE
KW  - RENAL-CELL CARCINOMA
KW  - SUPPRESSOR PROTEIN
KW  - NECK PARAGANGLIOMAS
KW  - SIGNALING PATHWAY
KW  - INDUCIBLE FACTORS
KW  - GENE-MUTATIONS
KW  - TCA CYCLE
KW  - IN-VITRO
KW  - PHEOCHROMOCYTOMAS
TI  - Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate
TY  - journal article
ER  -